Neurodevelopmental Pathways from Maternal Obesity to Offspring Outcomes: An Umbrella Review of Cognitive and

Evgenia Gkintoni1,2, Eleni Papachatzi1,3, Erifili Efthymiadou4

  • 1Laboratory of Public Health, Department of Medicine, University of Patras, 26504 Patras, Greece.

PubMed

Insights

Maternal obesity is linked to poorer child neurodevelopment, including lower IQ and more ADHD symptoms. Interventions targeting inflammatory, metabolic, and epigenetic pathways before and after conception may improve outcomes.

Area of Science:

  • Neuroscience
  • Developmental Biology
  • Public Health

Background:

  • Maternal obesity affects 20-25% of global pregnancies.
  • Linked to adverse offspring neurodevelopmental outcomes.
  • Umbrella review to synthesize evidence on neurodevelopmental pathways.

Purpose of the Study:

  • Synthesize evidence on neurodevelopmental pathways linking maternal obesity to offspring cognitive, executive, and behavioral outcomes.
  • Identify mechanistic pathways involved.
  • Assess the strength of evidence.

Main Methods:

  • Systematic umbrella review following PRISMA 2020 guidelines.
  • Searched six databases for studies published 2008-2024.
  • Included prospective cohorts, animal experiments, systematic reviews, neuroimaging, and RCTs.

Main Results:

  • 78 studies (650,000+ mother-child pairs) showed significant associations.
  • Maternal obesity linked to reduced cognitive abilities, impaired executive function, increased ADHD symptoms, and emotional dysregulation.
  • Identified inflammatory, metabolic, epigenetic, and neurotransmitter pathways; dose-response effects noted.

Conclusions:

  • Maternal obesity is a modifiable risk factor for offspring neurodevelopmental impairment.
  • Evidence from human observational and animal studies supports this link.
  • Multimodal interventions targeting identified pathways during critical windows warrant investigation.

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.1K
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
1.4K
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
736
Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
734
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
165